PhytoHealth Corporation
TWSE:4108.TW
17.6 (TWD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 162.489 | 135.465 | 168.936 | 91.81 | 95.485 | 107.483 | 53.996 | 25.021 | 20.978 | 90.732 | 144.988 | 177.711 | 155.092 | 107.904 | 99.193 |
| Cost of Revenue
| 94.846 | 78.433 | 90.623 | 46.307 | 31.906 | 52.416 | 29.783 | 12.531 | 18.274 | 88.889 | 146.379 | 161.914 | 144.42 | 98.612 | 87.395 |
| Gross Profit
| 67.643 | 57.032 | 78.313 | 45.503 | 63.579 | 55.067 | 24.213 | 12.49 | 2.704 | 1.843 | -1.391 | 15.797 | 10.672 | 9.292 | 11.798 |
| Gross Profit Ratio
| 0.416 | 0.421 | 0.464 | 0.496 | 0.666 | 0.512 | 0.448 | 0.499 | 0.129 | 0.02 | -0.01 | 0.089 | 0.069 | 0.086 | 0.119 |
| Reseach & Development Expenses
| 92.594 | 119.521 | 120.465 | 124.723 | 164.071 | 167.995 | 146.14 | 161.613 | 175.269 | 263.38 | 176.526 | 89.936 | 163.505 | 171.558 | 208.629 |
| General & Administrative Expenses
| 61.059 | 61.349 | 62.764 | 61.676 | 81.492 | 92.924 | 85.228 | 83.134 | 93.885 | 84.163 | 62.438 | 63.601 | 25.552 | 37.691 | 30.557 |
| Selling & Marketing Expenses
| 35.667 | 32.876 | 27.291 | 29.442 | 23.273 | 24.283 | 14.197 | 6.973 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 96.726 | 94.225 | 90.055 | 91.118 | 104.765 | 117.207 | 99.425 | 90.107 | 93.885 | 84.163 | 62.438 | 63.601 | 25.552 | 37.691 | 30.557 |
| Other Expenses
| -189.32 | 30.094 | 28.171 | 48.655 | 30.591 | 35.561 | 2.268 | 2.973 | 29.277 | -1.56 | 48.116 | 7.125 | 12.639 | 17.415 | 10.813 |
| Operating Expenses
| 189.32 | 213.746 | 210.52 | 215.841 | 299.427 | 323.9 | 292.566 | 251.72 | 269.154 | 347.543 | 238.964 | 153.537 | 204.111 | 227.969 | 255.38 |
| Operating Income
| -121.677 | -114.461 | -95.21 | -115.921 | -204.591 | -268.833 | -268.353 | -239.23 | -266.45 | -345.7 | -240.355 | -137.74 | -193.439 | -218.677 | -243.582 |
| Operating Income Ratio
| -0.749 | -0.845 | -0.564 | -1.263 | -2.143 | -2.501 | -4.97 | -9.561 | -12.701 | -3.81 | -1.658 | -0.775 | -1.247 | -2.027 | -2.456 |
| Total Other Income Expenses Net
| 47.53 | -0.262 | -0.306 | -0.339 | -0.175 | 60.061 | 24.437 | 25.317 | 29.277 | -1.56 | 48.116 | 25.763 | 4.929 | -6.046 | -25.022 |
| Income Before Tax
| -74.147 | -114.723 | -95.516 | -116.26 | -204.766 | -208.772 | -243.916 | -213.913 | -237.173 | -347.26 | -192.239 | -111.977 | -188.51 | -224.723 | -268.604 |
| Income Before Tax Ratio
| -0.456 | -0.847 | -0.565 | -1.266 | -2.144 | -1.942 | -4.517 | -8.549 | -11.306 | -3.827 | -1.326 | -0.63 | -1.215 | -2.083 | -2.708 |
| Income Tax Expense
| 47.874 | 0.312 | -17.495 | 2.395 | -33.839 | 60.219 | -37.622 | 15.177 | 4.989 | 0.024 | 0.024 | 0.011 | -5.358 | 0.022 | 0.091 |
| Net Income
| -74.147 | -115.035 | -78.021 | -118.655 | -170.927 | -182.476 | -206.349 | -194.516 | -203.5 | -321.702 | -182.964 | -103.794 | -170.071 | -215.119 | -267.053 |
| Net Income Ratio
| -0.456 | -0.849 | -0.462 | -1.292 | -1.79 | -1.698 | -3.822 | -7.774 | -9.701 | -3.546 | -1.262 | -0.584 | -1.097 | -1.994 | -2.692 |
| EPS
| -0.37 | -0.58 | -0.4 | -0.7 | -1.01 | -1.08 | -1.22 | -1.15 | -1.21 | -1.97 | -1.12 | -0.74 | -1.24 | -1.52 | -2.3 |
| EPS Diluted
| -0.37 | -0.58 | -0.4 | -0.7 | -1.01 | -1.08 | -1.22 | -1.15 | -1.21 | -1.91 | -1.09 | -0.74 | -1.24 | -1.51 | -2.28 |
| EBITDA
| -20.698 | -62.022 | -42.396 | -61.03 | -139.512 | -153.877 | -218.221 | -190.377 | -188.659 | -293.916 | -143.974 | -103.186 | -161.897 | -176.057 | -202.834 |
| EBITDA Ratio
| -0.127 | -0.458 | -0.251 | -0.665 | -1.461 | -1.432 | -4.041 | -7.609 | -8.993 | -3.239 | -0.993 | -0.581 | -1.044 | -1.632 | -2.045 |